ZEISS industry-leading GeminiSEM 500 imaging system to enhance the MACES open access microscopy imaging facility
ZEISS announces that it is providing its GeminiSEM 500, customized for nanomaterial characterization, to the University of California Merced’s Merced Nanomaterials Center for Energy and Sensing (MACES). The University’s recent purchase will support the university’s strong nanomaterial-based research programs and aid in the Center’s research in functional nanomaterials for energy and sensing for NASA missions...
With the World Health Organisation recently declaring the Zika virus the latest international public health emergency, pressure is growing on pharmaceutical manufacturers to rapidly increase production in order to meet spikes in demand.
Leading global asset management specialist, EquipNet Inc., has witnessed an increase in the number of pharma businesses purchasing pre-owned assets from other top-tier manufacturers to upscale production, as they realise the substantial time and cost savings that can be made. Ben Potenza, Vice President of Marketing at EquipNet, comments, “Pre-owned equipment is generally available immediately and delivery can be...
Discovery Park’s reputation as a centre for science innovation is set to grow even further in the months ahead thanks to a new investment fund located at the Sandwich site.
NCL Innovation, the UK’s leading early stage technology investor, has set up the Discovery Park Technology Investment Fund, which will help cutting edge science and technology firms to get their products or treatments to market. The new fund is managed by NCL and supported by Kent County Council and the Regional Growth Fund with the companies supported by the scheme given the investment and backing they...
The new All-Party Parliamentary Group (APPG) on Personalised Medicine held its official launch event in the House of Commons today with Life Sciences Minister George Freeman.
The Group aims to help the NHS and patients make best use of the increasing availability of cutting-edge technologies to provide more personalised health and care. The PHG Foundation, an independent health policy think tank that aims to make science work for health, provides the Secretariat for the new Group, supported by partners the Northern Health Science Alliance (NHSA), the Wellcome Trust Sanger Institute and...
BioTek Instruments is proud to announce that President and CEO Briar Alpert was named to the Board of Trustees at the University of Vermont (UVM) as of March 1, 2016.
As part of this six-year term, Mr. Alpert will advise and support UVM management on policy, budgets, strategic planning and other matters to ensure the University’s long-term vision and success. Mr. Alpert has far-reaching ties with the University, having earned his MBA and a BS in mechanical engineering from UVM. Additionally, his father and BioTek’s founder, Dr. Norman Alpert, was an internationally recognized expert in...
Fundraise will support commercial expansion and translational product development
Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, today announced the close of a $21 million Series B financing and the appointment of Dr. Geoff Smith as CEO. The round was led by GV (formerly Google Ventures), with significant participation from Sequoia Capital. Current investors New Science Ventures, Syncona Partners and Cambridge University also joined the round...
Atlas Genetics Ltd, the ultra- rapid Point-Of-Care (POC) molecular diagnostics company, today announces that it has been awarded an SBRI grant from Innovate UK to assist in the development of an ultra-rapid POC multiplex STI test measuring the four most commonly occurring pathogens (Chlamydia trachomatis, Neisseria gonorrhoea, Trichomonas vaginalis and Mycoplasma genitalium) in less than 30 minutes.
Atlas Genetics will develop an ultra-rapid POC stratified medicine diagnostic for patients presenting to Sexual Health Clinics with urethritis, which will allow immediate and accurate selection of appropriate and effective antibiotic treatment. Atlas will be collaborating with the Applied Diagnostic Research and Evaluation Unit at St George’s, University of London and Aquarius Population Health. Key elements of this project include...
Postnova Analytics, the leading international supplier of Field-Flow Fractionation (FFF) systems, has opened a dedicated office to enhance local support for its growing base of UK customers.
The new company, Postnova Analytics UK Ltd., is based in Herefordshire, and headed up by Paul Clarke - an industry professional with over 30 years experience in separation sciences. In addition to expediting service and support for existing systems, the new Postnova Analytics UK office has invested in a well-equipped laboratory for demonstrations and applications development in the separation of particles, polymers...
Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition.
The iGEM Foundation conducts a yearly international competition for students interested in synthetic biology. Last year, more than 280 teams from 39 countries participated in the competition. IDT also will provide each registered team with up to 20KB of its market leading gBlocks® Gene Fragments synthetic DNA products—for a total value of almost US$1M. “We are very proud to continue our support of iGEM teams that enable...
Merck, a leading science and technology company, reported record results for 2015, emerging stronger from the transformation process that started in 2007. Net sales and EBITDA pre exceptionals were higher than ever before in Merck’s history of nearly 350 years.
“2015 was not only an eventful, but above all a very successful year for Merck. We again achieved profitable growth. By acquiring Sigma-Aldrich, we successfully completed the portfolio realignment of recent years. In immuno-oncology, we initiated six pivotal clinical trials. Research advances and future-oriented investments form the foundation for future success. And our new bold and vibrant branding shows what makes Merck unique,” said Karl-Ludwig Kley, Chairman of the Executive Board....
Universities, funders and publishers of research do not adequately value the contributions of individuals who participate in “team science”, particularly those at the early stages of their research careers, according to a new report from the Academy of Medical Sciences.
As Team Science becomes more common, this lack of credit, if not addressed, could lead talented people to drop out of science, abandon research or avoid participating in large collaborative projects. Team science, or collaborative and multidisciplinary research, is increasingly at the heart of biomedical discoveries and breakthroughs. It is essential to tackle global issues which require the contribution of different disciplines and...
TxCell SA , a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today the launch of its new process industrialization laboratories and technology transfer academy facilities in Sophia Antipolis, France.
These new facilities will be primarily dedicated to the improvement of the existing TxCell manufacturing process for its ASTrIA platform as well as to the development of a manufacturing process for its new ENTrIA platform. These developments will be primarily achieved by combining the integration into the manufacturing process of findings from TxCell research with industry advancements in the life science and technology.
Until 30th June 2016 researchers and technicians can enjoy savings of up to 25% off selected products with the Eppendorf Advantage™ Spring offers.
During the promotional period, a wide range of Eppendorf’s high quality, affordable solutions, including the Eppendorf Xplorer®, epMotion®, Mastercycler® nexus gradient, HeatSealer S100, and MiniSpin® plus are being offered at a special reduced rate. Designed to deliver improved efficiency and productivity in the laboratory, Eppendorf’s solutions reach new levels of simplicity allowing work to be carried out easier and faster...
Life Science’s Minister George Freeman MP visited Charnwood Campus in Loughborough to meet the team responsible for the transformation of the world-class pharmaceutical site, and to discuss its potential role in strengthening the local economy.
His visit coincided with the publication of a new report, ‘Transforming Life Sciences Sites – a toolkit for action’ by a group of senior stakeholders from across the UK¹. During his tour, the Minister was briefed on how the anchor tenant, Almac Group, is upgrading the facilities to provide office and laboratory space, analytical testing, formulation development, and small and large scale manufacturing facilities. Senior Almac representatives presented...
We bring you more exciting news about Photonex London Roadshow.
The programme has now been finalised with an excellent calibre of speakers set to give presentations. Attend this event to broaden your knowledge in the world of photonics by attending a key meeting for photonics technologies in the life sciences. The technical committee have commented that this international quality 'invited' programme includes presentations by eminent and leading European research scientists...
Bedfont Scientific Ltd. has sold its U.K. subsidiary, NOxBOX Ltd, to Praxair Gases UK, Ltd., a subsidiary of Praxair, a Fortune 250 company with 2015 sales of $11 billion and one of the largest industrial gas companies worldwide.
Financial terms of the transaction were not disclosed. Bedfont’s sale of NOxBOX Ltd includes the full NOxBOX range of critical care delivery and monitoring devices for inhaled nitric oxide therapy. This announcement comes shortly after Bedfont announced the move to create the subsidiary NOxBOX Ltd after unprecedented success with the NOxBOX® range of products, which have been globally available in different forms since 1997...
World renowned standards company, Whitehouse Scientific, will exhibit its unique range of filter calibration products and services on Booth A1212 at the 12th World Filtration Congress (Taipei International Convention Center, Taiwan: 11-15th April 2016).
Dr Graham Rideal, CEO of Whitehouse Scientific, will also present a paper on the latest developments in wet challenge testing to accurately define pore size in a filter, to an audience of scientists, engineers and practitioners operating in the filtration field. Dr Rideal™s presentation, Latest Developments in Wet Challenge Testing, will highlight the importance of being able to accurately measure maximum pore size in filters across a wide...
OHAUS manufactures an extensive line of high-precision electronic and mechanical balances and scales that meet the demands of virtually any weighing need. The company is a global leader in the laboratory, industrial, and education channels as well as a host of specialty markets, including the food preparation, pharmacy and jewelry industries. OHAUS products are precise, reliable and affordable, and are backed by industry-leading customer support.
Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou™s intellectual property.
The license is subject to a research use limited label. "We are proud to partner with Integrated DNA Technologies, a prominent leader in the field of nucleic acid based technologies",
PAREXEL International Corporation a leading global biopharmaceutical services organisation, today announced expanded services and capabilities in genomic-based drug development.
The PAREXEL® Genomic Medicine team offers clients a variety of strategic and operational genomic research services to accelerate drug development and to support regulatory and payer approval processes. Biopharmaceutical companies are increasingly applying genomics to drug discovery and development to better understand the genetic basis of disease, drug targets, and drug response. Over the next five years...
Haydale, a leader in the development of enhanced graphene and nanoparticulate materials, has announced that it has been awarded a number of research grants, totalling £350k, which will help accelerate the development of new products enhanced by the incorporation of functionalised graphene and other nanomaterials.
These new projects include:The development of electrically conductive graphene enhanced adhesives for aircraft structures. The ability to conduct electricity from lightning strikes throughout a composite aircraft fuselage, including bonded joints, is essential for improved safety. This work builds on an existing research project to develop electrically conductive carbon fibre composite materials for aircraft construction...
Dean Street Express Expanding to Additional Locations using GeneXpert Infinity System
Cepheid have announced the delivery of the 10,000th GeneXpert® System to the 10 Hammersmith Broadway Clinic in London, England. The Hammersmith Clinic is the first in a series of new clinics developed by the same team behind the innovative Dean Street Express clinic located in London’s Soho district that has been transforming the model for STD testing and public health since it first opened in February 2014. Dean Street Express.....
Read More
ZEISS announces that it is providing its GeminiSEM 500, customized for nanomaterial characterization, to the University of California Merced’s Merced Nanomaterials Center for Energy and Sensing (MACES). The University’s recent purchase will support the university’s strong nanomaterial-based research programs and aid in the Center’s research in functional nanomaterials for energy and sensing for NASA missions...
Leading global asset management specialist, EquipNet Inc., has witnessed an increase in the number of pharma businesses purchasing pre-owned assets from other top-tier manufacturers to upscale production, as they realise the substantial time and cost savings that can be made. Ben Potenza, Vice President of Marketing at EquipNet, comments, “Pre-owned equipment is generally available immediately and delivery can be...
NCL Innovation, the UK’s leading early stage technology investor, has set up the Discovery Park Technology Investment Fund, which will help cutting edge science and technology firms to get their products or treatments to market. The new fund is managed by NCL and supported by Kent County Council and the Regional Growth Fund with the companies supported by the scheme given the investment and backing they...
The Group aims to help the NHS and patients make best use of the increasing availability of cutting-edge technologies to provide more personalised health and care. 
As part of this six-year term, Mr. Alpert will advise and support UVM management on policy, budgets, strategic planning and other matters to ensure the University’s long-term vision and success. Mr. Alpert has far-reaching ties with the University, having earned his MBA and a BS in mechanical engineering from UVM. Additionally, his father and BioTek’s founder, Dr. Norman Alpert, was an internationally recognized expert in...
Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, today announced the close of a $21 million Series B financing and the appointment of Dr. Geoff Smith as CEO. The round was led by GV (formerly Google Ventures), with significant participation from Sequoia Capital. Current investors New Science Ventures, Syncona Partners and Cambridge University also joined the round...
Atlas Genetics will develop an ultra-rapid POC stratified medicine diagnostic for patients presenting to Sexual Health Clinics with urethritis, which will allow immediate and accurate selection of appropriate and effective antibiotic treatment. Atlas will be collaborating with the Applied Diagnostic Research and Evaluation Unit at St George’s, University of London and Aquarius Population Health. Key elements of this project include...
The new company, Postnova Analytics UK Ltd., is based in Herefordshire, and headed up by Paul Clarke - an industry professional with over 30 years experience in separation sciences. In addition to expediting service and support for existing systems, the new Postnova Analytics UK office has invested in a well-equipped laboratory for demonstrations and applications development in the separation of particles, polymers...
The iGEM Foundation conducts a yearly international competition for students interested in synthetic biology. Last year, more than 280 teams from 39 countries participated in the competition. IDT also will provide each registered team with up to 20KB of its market leading gBlocks® Gene Fragments synthetic DNA products—for a total value of almost US$1M. “We are very proud to continue our support of iGEM teams that enable...
“2015 was not only an eventful, but above all a very successful year for Merck. We again achieved profitable growth. By acquiring Sigma-Aldrich, we successfully completed the portfolio realignment of recent years. In immuno-oncology, we initiated six pivotal clinical trials. Research advances and future-oriented investments form the foundation for future success. And our new bold and vibrant branding shows what makes Merck unique,” said Karl-Ludwig Kley, Chairman of the Executive Board....
As Team Science becomes more common, this lack of credit, if not addressed, could lead talented people to drop out of science, abandon research or avoid participating in large collaborative projects. Team science, or collaborative and multidisciplinary research, is increasingly at the heart of biomedical discoveries and breakthroughs. It is essential to tackle global issues which require the contribution of different disciplines and...
These new facilities will be primarily dedicated to the improvement of the existing TxCell manufacturing process for its ASTrIA platform as well as to the development of a manufacturing process for its new ENTrIA platform. These developments will be primarily achieved by combining the integration into the manufacturing process of findings from TxCell research with industry advancements in the life science and technology.
During the promotional period, a wide range of Eppendorf’s high quality, affordable solutions, including the Eppendorf Xplorer®, epMotion®, Mastercycler® nexus gradient, HeatSealer S100, and MiniSpin® plus are being offered at a special reduced rate. Designed to deliver improved efficiency and productivity in the laboratory, Eppendorf’s solutions reach new levels of simplicity allowing work to be carried out easier and faster...
His visit coincided with the publication of a new report, ‘Transforming Life Sciences Sites – a toolkit for action’ by a group of senior stakeholders from across the UK¹. During his tour, the Minister was briefed on how the anchor tenant, Almac Group, is upgrading the facilities to provide office and laboratory space, analytical testing, formulation development, and small and large scale manufacturing facilities. Senior Almac representatives presented...
The programme has now been finalised with an excellent calibre of speakers set to give presentations. Attend this event to broaden your knowledge in the world of photonics by attending a key meeting for photonics technologies in the life sciences. The technical committee have commented that this international quality 'invited' programme includes presentations by eminent and leading European research scientists...
Financial terms of the transaction were not disclosed. Bedfont’s sale of NOxBOX Ltd includes the full NOxBOX range of critical care delivery and monitoring devices for inhaled nitric oxide therapy. This announcement comes shortly after Bedfont announced the move to create the subsidiary NOxBOX Ltd after unprecedented success with the NOxBOX® range of products, which have been globally available in different forms since 1997...
Dr Graham Rideal, CEO of Whitehouse Scientific, will also present a paper on the latest developments in wet challenge testing to accurately define pore size in a filter, to an audience of scientists, engineers and practitioners operating in the filtration field. Dr Rideal™s presentation, Latest Developments in Wet Challenge Testing, will highlight the importance of being able to accurately measure maximum pore size in filters across a wide...
OHAUS manufactures an extensive line of high-precision electronic and mechanical balances and scales that meet the demands of virtually any weighing need. The company is a global leader in the laboratory, industrial, and education channels as well as a host of specialty markets, including the food preparation, pharmacy and jewelry industries. OHAUS products are precise, reliable and affordable, and are backed by industry-leading customer support.
The license is subject to a research use limited label. "We are proud to partner with Integrated DNA Technologies, a prominent leader in the field of nucleic acid based technologies",
The PAREXEL® Genomic Medicine team offers clients a variety of strategic and operational genomic research services to accelerate drug development and to support regulatory and payer approval processes. Biopharmaceutical companies are increasingly applying genomics to drug discovery and development to better understand the genetic basis of disease, drug targets, and drug response. Over the next five years...
These new projects include: The development of electrically conductive graphene enhanced adhesives for aircraft structures. The ability to conduct electricity from lightning strikes throughout a composite aircraft fuselage, including bonded joints, is essential for improved safety. This work builds on an existing research project to develop electrically conductive carbon fibre composite materials for aircraft construction...